Ten big pharma companies collaborate on data sharing AI
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
List view / Grid view
News
EU conditional marketing authorisation announced for ZYNTEGLO
ZYNTEGLO™ is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT).
Study reveals potential for malaria prevention vaccine
Researchers have identified a novel drug target for the prevention of malaria.
Molecule which targets Parkinson’s protein identified
A new study has identified a molecule which targets a protein linked with Parkinson’s.
‘CRISPR babies’ may have shorter life expectancy
A study of almost half a million people links a mutation that protects against HIV infection to an earlier death.
Decision issued on US stem cell clinics accused of violating the law
The court held that the defendants adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue.
Study shows that immune cells determine growth of certain tumours
A new study shows that the growth rate of a tumour does not depend solely on how quickly the cancer cells can divide.
Regenerative medicine research boosted by stem cell discovery
A novel way to create Expanded Potential Stem Cells has generated opportunities to research regenerative medicine.
New study brings universal flu vaccine a step closer
An international team of researchers has proven that targeting a specific area of the flu virus protects humans.
Gut microbiome identified as cause of IBD, study finds
A study has detailed the change in the gut microbiome, increasing the potential for new IBD therapies.
Female animals should be included in trials, new argument proposes
Using exclusively male animals in experiments biases results, argues Rebecca Shansky.
High-res 3D structure of proteins inside living eukaryotic cells determined
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
Study identifies novel lupus drug target
Structure of internal regulator molecule identified, presenting lupus drug potential.
US company put on notice for marketing unapproved stem cell products
Arizona company claims their products can treat Lyme disease, diabetes, Parkinson’s disease and more, but have not been approved for any use.
Proteomics research advanced by use of AI
Researchers succeed in using machine learning to make the mass analysis of proteins faster and almost error-free.